Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Exact Sciences Corporation
EXKCurrent price
63.14 EUR
-1.18 EUR (-1.82%)
Last closed
64.31 EUR
Company
–
ISIN
US30063P1057
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
Frankfurt Exchange
Capitalization
12 004 450 691 EUR
Yield for 12 month
+7.44 %
1Y
3Y
5Y
10Y
15Y
EXK
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Address: 5505 Endeavor Lane, Madison, WI, United States, 53719
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
137.41 EURP/E ratio
–Dividend Yield
–Current Year
+2 307 121 533 EUR
Last Year
+1 923 654 039 EUR
Current Quarter
+645 375 220 EUR
Last Quarter
+588 393 213 EUR
Current Year
+1 703 337 456 EUR
Last Year
+1 393 525 712 EUR
Current Quarter
+470 202 157 EUR
Last Quarter
+431 401 969 EUR
Key Figures EXK
1 year
3 years
5 years
10 years
EBITDA
-68 779 379 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-2.71 %
PEG Ratio
–
Return On Equity TTM
-5.6 %
Wall Street Target Price
137.41 EUR
Revenue TTM
2 607 400 415 EUR
Book Value
17.26 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
12.4 %
Dividend Yield
–
Gross Profit TTM
1 507 219 826 EUR
Earnings per share
-0.88 EUR
Diluted Eps TTM
-0.88 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-6.7 %
Dividend Analytics EXK
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EXK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation EXK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2500
Enterprise Value Revenue
5.5836
Price Sales TTM
4.604
Enterprise Value EBITDA
210.5245
Price Book MRQ
4.0469
Financials EXK
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EXK
For 52 weeks
38.29 EUR
69.23 EUR
50 Day MA
59.09 EUR
Shares Short Prior Month
–
200 Day MA
53.33 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart